Results 171 to 180 of about 277,563 (295)

Effects of Changes in Metabolic Syndrome Status on Cognitive Function: A 10‐Year Study in a Middle‐Aged Population

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The long‐term cumulative impact of metabolic syndrome (MS) on cognitive decline remains uncertain. This study investigated how changes in MS status over 10 years relate to cognition and whether sex modifies this relationship. A total of 766 participants (mean baseline age: 54 years) from the Kaohsiung Atherosclerosis Longitudinal Study were ...
Kelly Lim, Meng‐Ni Wu, Wei‐Chia Tsao, Wei‐Hao Lin, Suh‐Hang Hank Juo, Cheng‐Sheng Chen, Hsiu‐Fen Lin   +6 more
wiley   +1 more source

Apolipoproteins and high-density lipoprotein phospholipids as indicators of atherosclerotic cardiovascular disease in Nigeria. [PDF]

Afr J Lab Med
Nwaejigh PC, Ebesunun MO, Udofia SS, Shakunle AA.   +3 more
europepmc   +1 more source

Chronic thrombin exposure results in an increase in apolipoprotein-E levels

, 2006
Molina Mhatre, Kenneth Hensley, Albert Nguyen, Paula Grammas   +3 more
openalex   +1 more source

High-Mobility Group Box Protein 1 Neutralization Reduces Development of Diet-Induced Atherosclerosis in Apolipoprotein E–Deficient Mice [PDF]

, 2010
Peter Kanellakis, Alex Agrotis, Tin Kyaw, Christine Koulis, Ingo Ahrens, Shuji Mori, Hideo Takahashi, Keyue Liu, Karlheinz Peter, Masahiro Nishibori, Alex Bobik   +10 more
openalex   +1 more source

Impact of CYP2C19 Genotype Variants on PCSK9 Inhibitor Efficacy in Lipid‐Lowering Among Patients With Symptomatic Intracranial Atherosclerotic Stenosis

Lipids, EarlyView.
ABSTRACT Ischemic stroke is frequently associated with symptomatic intracranial atherosclerotic stenosis (sICAS), is a leading cause of global disability and mortality. Current guidelines recommend dual antiplatelet and intensive statin therapies. Proprotein convertase subtilisin 9/kexin type 9 (PCSK9) inhibitors have emerged as a potent lipid‐lowering
Chao Zhao, Nuan Wang, Di Shi, Hao Zhou, Dan Chen, Guofang Chen   +5 more
wiley   +1 more source

Serum Apolipoprotein B Levels and Apolipoprotein B/Apolipoprotein A1 Ratio as Predictors of Dyslipidemia Risk in Patients Treated with Second-Generation Antipsychotics: A Retrospective Cohort Study. [PDF]

Neuropsychiatr Dis Treat
Zhang JX, Huang ZQ, Yang JM, Wang WY, Li WN.   +4 more
europepmc   +1 more source

Changes in Plasma Sphingolipid Metabolites Following Roux‐En‐Y Gastric Bypass in Women With Obesity and Type 2 Diabetes: A Pilot Metabolomic Cohort Study

Lipids, EarlyView.
ABSTRACT Although sphingolipids are key players in lipotoxicity and metabolic diseases, their response to bariatric surgery and their relation to metabolic improvement remain unclear. This pilot study investigated plasma sphingolipid remodeling after Roux‐en‐Y gastric bypass (RYGB) and its associations with clinical and biochemical markers of ...
Gabriela de Oliveira Lemos, Raquel Susana Torrinhas, Natasha Mendonça Machado, Dan Linetzky Waitzberg   +3 more
wiley   +1 more source

Elevated serum lipoprotein(a) as a prognostic marker for reduced survival in pancreatic cancer. [PDF]

BMC Gastroenterol
Liu J, Jiang Y, Xing Y, Wang S, Ma B, Guo M, Jing X, Liu L.   +7 more
europepmc   +1 more source

Apolipoprotein A-I and B levels in Bangladeshi patients with coronary artery disease

, 2016
Ashesh Kumar Chowdhury, Abu Mohammed Shafique, Zeenat Farzana Rahman   +2 more
openalex   +2 more sources

Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis [PDF]

, 2011
Micha M.M. Wilhelmus, John G. J. M. Bol, Elise S. van Haastert, Annemieke J.M. Rozemüller, Guojun Bu, Benjamin Drukarch, Jeroen J.M. Hoozemans   +6 more
openalex   +1 more source